The interchangeability of biological medicines still raises many controversies and doubts. On 18 June 2018 took place a seminar “Substitution-Interchangeability-Switch of biological drugs”, fully dedicated to this topic. One of the speakers was Monika Duszyńska, who spoke on regulatory agencies’ and EU guidelines on switches and substitution of biological medicines.